Ulrik C S, Lange P
Department of Pulmonary Medicine P, Bispebjerg Hospital, Copenhagen, Denmark.
Am J Respir Crit Care Med. 1994 Sep;150(3):629-34. doi: 10.1164/ajrccm.150.3.8087330.
To investigate the annual decline of lung function in subjects with self-reported asthma, we analyzed data from a longitudinal epidemiologic study. The Copenhagen City Heart Study. The study sample consisted of 10,952 subjects (4,824 men), 20 to 90 yr of age, randomly selected from the city of Copenhagen followed over a 5-yr period. The overall prevalence of asthma was 3.7% (n = 177) in men and 3.6% (n = 219) in women. Subjects who reported asthma at the first examination had, in general, lower values for lung function than did nonasthmatic subjects, which was also the case for subjects who developed asthma during follow-up (new asthma). The annual loss of FEV1 increased with age among both asthmatics and nonasthmatics. Multiple regression analysis showed a higher decline of FEV1 in subjects with new asthma. The excess decline was, on average, 39 ml/yr in men (p = 0.002) and 11 ml/yr in women (NS), respectively, compared with that in nonasthmatic subjects. In subjects with chronic asthma, the decline was not increased compared with that in nonasthmatic subjects. Separate analyses of lifelong nonsmokers revealed that the excess decline of FEV1 in subjects with new asthma was, on average, 33 ml/yr, whereas it was not significantly increased in subjects with chronic asthma. In conclusion, this study of a large sample from the general population showed that the rate of decline of FEV1 is increased in subjects with new asthma, whereas in subjects with chronic asthma the decline of FEV1 did not differ significantly from the decline in the nonasthmatic subjects.
为了研究自我报告患有哮喘的受试者肺功能的年度下降情况,我们分析了一项纵向流行病学研究——哥本哈根市心脏研究的数据。研究样本包括10952名年龄在20至90岁之间的受试者(4824名男性),他们是从哥本哈根市随机选取的,并随访了5年。男性哮喘的总体患病率为3.7%(n = 177),女性为3.6%(n = 219)。在首次检查时报告患有哮喘的受试者,其肺功能值通常低于非哮喘受试者,在随访期间出现哮喘的受试者(新发哮喘)也是如此。哮喘患者和非哮喘患者的第一秒用力呼气容积(FEV1)的年度损失均随年龄增加。多元回归分析显示,新发哮喘受试者的FEV1下降幅度更大。与非哮喘受试者相比,男性新发哮喘受试者FEV1的额外下降平均为每年39毫升(p = 0.002),女性为每年11毫升(无统计学意义)。在慢性哮喘受试者中,与非哮喘受试者相比,下降幅度并未增加。对终生不吸烟者的单独分析显示,新发哮喘受试者FEV1的额外下降平均为每年33毫升,而慢性哮喘受试者的FEV1没有显著增加。总之,这项对来自普通人群的大样本研究表明,新发哮喘受试者的FEV1下降速率增加,而慢性哮喘受试者的FEV1下降与非哮喘受试者相比无显著差异。